Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.184.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 34.12% | 455.81% | 162.39% | 456.27% | -8.44% |
| Total Receivables | -30.07% | 23.44% | 502.35% | 2,098.76% | 233.26% |
| Inventory | 8.78% | 103.02% | -- | -- | -- |
| Prepaid Expenses | 72.96% | 97.61% | 126.89% | 68.03% | 27.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 161.29% | 101.38% | -- | -- | 100.72% |
| Total Current Assets | 30.16% | 346.25% | 169.28% | 454.90% | 9.92% |
|
|
|||||
| Total Current Assets | 30.16% | 346.25% | 169.28% | 454.90% | 9.92% |
| Net Property, Plant & Equipment | 46.27% | -0.12% | 12.38% | 24.93% | 16.34% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -100.00% | -74.17% | -74.18% | -74.19% | -74.19% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -49.81% | -39.10% | 6.14% | 9.54% | 10.54% |
| Total Assets | -26.58% | -37.43% | -32.39% | -14.95% | -53.16% |
|
|
|||||
| Total Accounts Payable | 55.03% | 21.10% | 21.50% | 150.99% | 72.19% |
| Total Accrued Expenses | 77.48% | -1.42% | 12.20% | 29.95% | 27.79% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.54% | 24.55% | 49.66% | 71.01% | 94.74% |
| Total Finance Division Other Current Liabilities | 87.72% | -63.93% | -70.22% | -81.29% | -90.33% |
| Total Other Current Liabilities | 87.72% | -63.93% | -70.22% | -81.29% | -90.33% |
| Total Current Liabilities | 65.98% | -15.73% | -7.59% | 16.28% | 1.13% |
|
|
|||||
| Total Current Liabilities | 65.98% | -15.73% | -7.59% | 16.28% | 1.13% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -28.66% | -43.54% | -30.48% | -17.50% | 7.49% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.23% | -9.78% | -2.96% | -11.17% | -5.49% |
| Total Liabilities | 20.83% | -12.18% | -4.99% | -7.24% | -3.94% |
|
|
|||||
| Common Stock & APIC | 9.16% | 12.81% | 12.80% | 18.30% | 9.01% |
| Retained Earnings | -14.33% | -19.17% | -20.89% | -19.47% | -20.93% |
| Treasury Stock & Other | 309.52% | 50.88% | 129.73% | 2.50% | -57.14% |
| Total Common Equity | -156.35% | -194.70% | -95.16% | -11.82% | -159.97% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -156.35% | -194.70% | -95.16% | -11.82% | -159.97% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -156.35% | -194.70% | -95.16% | -39.61% | -147.96% |
|
|
|||||